8-K: Nature's Miracle Secures $2M, Expands Preferred Stock

Nature's Miracle Holding Inc. has entered into two significant securities purchase agreements, raising $2 million through Series D preferred stock and issuing Series A preferred stock for strategic consents, while also amending its preferred stock designations.

Summary

• Secured $2,000,000 through the sale of 2,000 shares of Series D preferred stock to Y. K. Capital Management, Inc.
• The Series D preferred stock has a stated value of $1,000 per share and bears an 8% annual dividend, payable quarterly in cash or preferred stock at the company's discretion.
• Series D shares are convertible into common stock at a conversion price of $0.1180 per share, with a 4.99% beneficial ownership conversion limit.
• The Series D capital raise is structured in three closings: $500,000 initially, $500,000 by October 30, 2025, and $1,000,000 prior to uplisting to NYSE or Nasdaq.
• Issued 50 shares of existing Series A preferred stock to GHS Investments LLC in consideration for their consent to several strategic transactions.
• The Series A preferred stock has a stated value of $1,200 per share and bears a 12% annual dividend, convertible into common stock at $0.112 per share, also with a 4.99% beneficial ownership conversion limit.
• Strategic transactions consented to by GHS Investments LLC include creating Series B, C, and D convertible preferred stock, issuing 5,000 Series B shares (with 20-1 super voting rights), issuing 9,500 Series C shares for acquiring assets from CEO James Li, and issuing a $3,000,000 promissory note to an affiliate of James Li.
• Amended the Certificate of Designations for Series A Preferred Stock to increase the designated Series B Preferred Stock from 250 to 300 shares.
• Filed and subsequently amended the Certificate of Designations for Series D Preferred Stock, formally designating 2,000 shares.

Sentiment

Score: 3

Explanation: While the company successfully raised capital, the terms of the preferred stock (high dividends, low conversion prices, significant dilution) and the nature of related-party transactions suggest a challenging financial position and potential governance issues. The explicit acknowledgment of 'substantial dilution' and potential negative impact on stock price by management further dampens sentiment.

Positives

• Successfully raised $2,000,000 in capital through the issuance of Series D preferred stock, providing funding for operations or strategic initiatives.
• The Series D preferred stock includes a redemption obligation for the company, offering a potential exit for investors.
• Secured investor consent for significant corporate restructuring, including the creation of new preferred stock series and an asset acquisition from the CEO.

Negatives

• The issuance of preferred stock, especially Series B with 20-1 super voting rights, can significantly dilute the voting power of existing common stockholders.
• The acquisition of assets from CEO James Li using Series C stock and a $3,000,000 promissory note to an affiliate of James Li raises concerns about potential conflicts of interest and related-party transactions.
• High dividend rates on preferred stock (8% for Series D, 12% for Series A) represent a significant ongoing financial obligation for the company.
• The conversion prices for Series D ($0.1180) and Series A ($0.112) preferred stock are very low, indicating substantial potential dilution for common shareholders upon conversion.
• The 'Most Favored Nations' clause for the Series A investor could lead to further dilution or more onerous terms for future capital raises if subsequent investors receive better terms.

Risks

• Dilution Risk: Significant dilution of voting power and equity for existing common stockholders due to the issuance and potential conversion of Series A, B, C, and D preferred stock.
• Financial Obligation Risk: High fixed dividend rates (8% and 12% per annum) on preferred stock create substantial ongoing financial obligations, which could strain cash flow.
• Related Party Transaction Risk: The acquisition of assets from CEO James Li and the issuance of a $3,000,000 promissory note to his affiliate present potential conflicts of interest and governance concerns.
• Uplisting Risk: The final tranche of Series D funding is contingent on the company's application for uplisting to NYSE or Nasdaq, which is not guaranteed and could be delayed or fail.
• Conversion Price Risk: The low conversion prices ($0.1180 for Series D, $0.112 for Series A) mean a large number of common shares will be issued upon conversion, further increasing dilution.
• Event of Default Risk: Specific events, such as stock delisting, failure to meet reporting requirements, or failure to pay dividends, trigger a higher redemption price (125% of stated value plus 15% interest), increasing financial risk.
• Market Price Impact Risk: Management acknowledges that past or future open market or derivative transactions by purchasers may negatively impact the market price of the company's publicly-traded securities.

Future Outlook

The company intends to apply for uplisting its common stock to the NYSE or Nasdaq, which is a condition for the final $1,000,000 tranche of the Series D preferred stock investment. The company also commits to using its best efforts to file a registration statement for the resale of the newly issued securities within 30 calendar days from closing.

Management Comments

• Management acknowledges that the issuance of the Securities will result in substantial dilution of the voting power of the outstanding shares of Common Stock.
• Management acknowledges that past or future open market or other transactions by the Purchaser, specifically including, without limitation, derivative transactions, before or after a closing of this or future private placement transactions, may negatively impact the market price of the company’s publicly-traded securities.

Industry Context

The transactions reflect a company seeking capital and restructuring its equity base, common for smaller or emerging growth companies aiming for broader market access (e.g., uplisting to major exchanges). The use of preferred stock with high dividends and low conversion prices is typical for companies that may find it challenging to raise capital through common equity without significant price concessions. The related-party transactions are a notable aspect that warrants scrutiny in corporate governance.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• Issuance of 9,500 shares of Series C Stock in a transaction to acquire certain assets owned by James Li, the company's Chief Executive Officer.
• Issuance of a promissory note in favor of an affiliate of James Li in the aggregate principal amount of $3,000,000.

Stakeholder Impact

• Shareholders (Common Stock): Significant dilution of voting power and equity value due to the issuance of multiple series of preferred stock with low conversion prices and super voting rights (Series B).
• Preferred Shareholders (Series D): Receive an 8% annual dividend and a redemption option, providing a structured return and potential exit.
• Preferred Shareholders (Series A): Receive a 12% annual dividend and provided consent for strategic transactions, indicating their influence on corporate decisions.
• Management (CEO James Li): Directly benefits from related-party transactions involving asset acquisition and a promissory note, raising questions about alignment of interests with common shareholders.

Next Steps

• Complete the second closing of Series D preferred stock purchase ($500,000) before October 30, 2025.
• Complete the third and final closing of Series D preferred stock purchase ($1,000,000) prior to the company's application for uplisting to NYSE or Nasdaq.
• File a registration statement for the resale of the securities within 30 calendar days from closing.
• Increase authorized common stock to no less than 300,000,000 shares to enable full conversion of Series D preferred stock.

Key Dates

Recommendation

The terms of the capital raise, particularly the high dividend rates on preferred stock and very low conversion prices, suggest a distressed financing scenario that will lead to substantial dilution for existing common shareholders. The significant related-party transactions involving the CEO and his affiliate, including asset acquisition and a $3 million promissory note, raise serious corporate governance concerns and potential conflicts of interest. Management explicitly acknowledges 'substantial dilution' and potential negative impact on the stock price from investor trading activities. These factors collectively point to a highly unfavorable outlook for common equity holders.

Keywords

Preferred Stock, Capital Raise, SEC Filing, Form 8-K, Convertible Securities, Series D Preferred Stock, Series A Preferred Stock, Corporate Governance, Dilution, Dividends, Securities Purchase Agreement, NMHI, Y. K. Capital Management, GHS Investments, Related Party Transaction, Uplisting